CCEL Cryo-Cell International Year-over-year earnings per share growth for the last twelve months

A seamless express delivery network for biomaterials ensures the operational stability of Cryo-Cell International (CCEL). Analyzing the volatility of the quarterly EPS on GURU.Markets, we find that the current value is 69.70. An expanding base of long-term contracts and new cellular products are driving growth, while its status as a global leader in cryobanking creates a predictable stream of passive income through annual client payments.

CCEL: Cryo-Cell International, Inc. Earnings per share growth in annualized terms for the last twelve months 07/04/2022 - 11/15/2026

Metric breakdowns and analytics for cryo-cell.com (CCEL)

- share price and expert price forecast:

Stock Price Cryo-Cell International Inc|CCEL - Consensus Target

- market capitalization data:

Market Value Cryo-Cell International, Inc.|CCEL - Value Adjusted for Debt and Cash

- book capitalization data:

Accounting Value per Share Cryo-Cell International|CCEL - Total Stockholders' Equity|Market Value to Book Value Ratio cryo-cell.com|CCEL - Company Assets

- business debt structure and liquidity details:

- earnings and valuation multiples information:

CCEL - Company Net Income|Future Profit Cryo-Cell International|CCEL - Company Value to Net Income|Forward P/E Multiple Cryo-Cell International|CCEL - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Cryo-Cell|CCEL - Operating profit before amortization|Net earnings per share for the last 12 months Cryo-Cell International|CCEL - Earnings per share for the last four quarters|Quarterly EPS earnings growth cryo-cell.com|CCEL - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Cryo-Cell International

- sales volume and revenue indicators:

CCEL - Company Sales Revenue|Company Projected Revenue Cryo-Cell International|CCEL - Market Cap to Revenue Ratio|Forward P/S Multiple CCEL|CCEL - Sales Growth YoY (TTM)

Basic company analysis:Cryo-Cell - CCEL

Finished products of Cryo-Cell International

Net income per share for Cryo-Cell International (CCEL) reflects the actual profitability of the business, which is subject to the inflationary cost increases of imported cryogenic equipment and consumables. By analyzing the quarterly EPS trend profile, an investor assesses the cash flow after taxes and subsidies, allowing them to filter out random fiscal spikes and confirm the stability of the company's fundamental asset value.

Analysis of competing companies

Mesoblast Pharma (MESO) - Year-over-year earnings per share growth for the last twelve months|LCTX (Lineage Bio) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months SRZN|FibroBiologics, Inc. (FBLG) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Longeveron Corp (LGVN)|BRTX - Earnings per share growth in annualized terms for the last twelve months|Quarterly EPS earnings growth CELZ (Creative Medical Technology Holdings, Inc.)